Inventor · disambiguated record
Jacques Dubois
Also filed as: DUBOIS JACQUES · DUBOIS JACQUES R N
9 granted patents·14 pending applications·194 citations·filing 1973–2014
89Inventor score
Top patents by PatentIndex Score
23 records- 0191US9254331B2Sulforaphane stabilizationDUBOIS JACQUES·Filed 2011·Granted Feb 9, 2016·58 cites·10 claims
- 0280US5075113AProducts comprising an emulsion of water and oily paraffinic hydrocarbons with added extracts of lecithin and processes for productionDUBOIS JACQUES·Filed 1989·Granted Dec 24, 1991·29 cites·1 claims
- 0373US6340689B1Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteriaSMITHKLINE BEECHAM CORP·Filed 1999·Granted Jan 22, 2002·36 cites·9 claims
- 0461US4164109AMethod and device for a tight packing under a thermoplastic and thermoformable film of products requiring an absolute protectionDUBOIS JACQUES R N·Filed 1977·Granted Aug 14, 1979·17 cites·6 claims
- 0561US2005288300A1Methods of use fluoroquinolone compounds against maxillary sinus pathogenic bacteriaLG LIFE SCIENCES LTD·Filed 2005·Application pending·0 cites
- 0659US6054138AStabilized pseudo-emulsions and their preparation processFABRE PIERRE DERMO COSMETIQUE·Filed 1996·Granted Apr 25, 2000·22 cites·22 claims
- 0756US2003119866A1Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteriaSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 0855US2003119867A1Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteriaFiled 2002·Application pending·0 cites
- 0954US2002137752A1Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteriaSMITHKLINE BEECHAM CORP·Filed 2001·Application pending·0 cites
- 1054US2003119865A1Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteriaSMITHKLINE BEECHAM CORP·Filed 2002·Application pending·0 cites
- 1153US6579837B1Terephthalic polyester composition and its use as soil release agentRHODIA CHIMIE SA·Filed 1999·Granted Jun 17, 2003·16 cites·17 claims
- 1252US2011280940A1Di-Vanilloyl And Tri-Vanilloyl Derivatives For Use In Anti-Cancer TherapyKISS ROBERT·Filed 2009·Application pending·0 cites
- 1350US2004180903A1Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteriaFiled 2003·Application pending·0 cites
- 1448US2010074851A1Cosmetic or pharmaceutical composition containing hyaluronic acidAURIGA INTERNAT S A·Filed 2007·Application pending·0 cites
- 1547US2005032813A1Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteriaFiled 2004·Application pending·0 cites
- 1645US4098879AN-alkyl-3-pyridinium-methanol fluorides and derivatives thereofFABRE SA PIERRE·Filed 1977·Granted Jul 4, 1978·5 cites·23 claims
- 1744US2002086867A1Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteriaSMITHKLINE BEECHAM CORP·Filed 2001·Application pending·0 cites
- 1836US3998362APortable hopper apparatus for supplying a dry mortar mixMIRON COMPANY LTD·Filed 1973·Granted Dec 21, 1976·11 cites·4 claims
- 1936US2012141618A1Process for preparing integral olive juice, using this process to obtain the composition and its application in the field of cosmetics and nutritionCOLICCI RAPHAEL·Filed 2010·Application pending·0 cites
- 2035US2013053347A1Pro-drugs of amaryllidaceae isocarbostyril products and their use against brain tumorsMATHIEU VERONIQUE·Filed 2010·Application pending·0 cites
- 2134US9669007B2Method for obtaining a stable gel of hyaluronic acid and of a free form of vitamin C and/or a salt thereofAURIGA INT·Filed 2014·Granted Jun 6, 2017·0 cites·12 claims
- 2233US2013142739A1Process for the synthesis of isothiocyanates and derivatives thereof and uses of sameDUBOIS JACQUES·Filed 2011·Application pending·0 cites
- 2325US2001049378A1Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteriaFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jacques Dubois files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →